Capitalization | 9.08TCr 7.88TCr 7.42TCr 6.74TCr 12TCr 7,86600Cr 14TCr 88TCr 34TCr 3,60300Cr 34TCr 33TCr 13,24600Cr | P/E ratio 2025 * |
14.9x | P/E ratio 2026 * | 13.4x |
---|---|---|---|---|---|
Enterprise value | 14TCr 12TCr 11TCr 10TCr 19TCr 11,73100Cr 21TCr 1,31100Cr 50TCr 5,37400Cr 51TCr 50TCr 19,75500Cr | EV / Sales 2025 * |
1.81x | EV / Sales 2026 * | 1.74x |
Free-Float |
71.58% | Yield 2025 * |
0.75% | Yield 2026 * | 0.78% |
More valuation ratios
* Estimated data
More news
Last Transcript: HCA Healthcare, Inc.
More recommendations
More press releases
More news
1 day | +0.17% | ||
1 week | +1.70% | ||
Current month | -1.02% | ||
1 month | +0.23% | ||
3 months | +14.81% | ||
6 months | +24.33% | ||
Current year | +25.77% |
1 week | 361.29 | ![]() | 380.56 |
1 month | 350.74 | ![]() | 386.56 |
Current year | 289.98 | ![]() | 388.38 |
1 year | 289.98 | ![]() | 417.14 |
3 years | 164.47 | ![]() | 417.14 |
5 years | 91.21 | ![]() | 417.14 |
10 years | 43.91 | ![]() | 417.14 |
Manager | Title | Age | Since |
---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 63 | 01/01/2019 |
Mike Marks
DFI | Director of Finance/CFO | 55 | 01/05/2024 |
Randy Fagin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director | Title | Age | Since |
---|---|---|---|
Thomas Frist
CHM | Chairman | 57 | 26/04/2019 |
William Frist
BRD | Director/Board Member | 55 | 01/01/2009 |
Samuel Hazen
BRD | Director/Board Member | 63 | 10/09/2018 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
1.96% | 6 M€ | 0.00% | - | |
1.88% | 21 M€ | -0.36% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.17% | +1.70% | +11.38% | +113.77% | 9.08TCr | ||
-0.40% | -1.32% | +8.47% | -27.08% | 8.42TCr | ||
+0.91% | -4.52% | +49.66% | +55.59% | 2.73TCr | ||
+1.22% | -4.29% | -13.26% | +26.03% | 2.3TCr | ||
+0.19% | +0.29% | +27.59% | +12.27% | 2.19TCr | ||
-0.19% | -0.43% | +29.12% | +33.56% | 2TCr | ||
+0.85% | -6.80% | +31.48% | +3.27% | 1.57TCr | ||
+0.26% | +2.21% | +25.15% | +209.52% | 1.56TCr | ||
-1.33% | -0.85% | +32.07% | +16.31% | 1.39TCr | ||
+4.45% | -1.59% | +31.11% | +232.71% | 1.36TCr | ||
Average | +0.61% | -1.31% | +23.28% | +67.60% | 3.26TCr | |
Weighted average by Cap. | +0.29% | -0.71% | +17.61% | +54.66% |
2025 * | 2026 * | |
---|---|---|
Net sales | 7.47TCr 6.48TCr 6.11TCr 5.55TCr 10TCr 6,47300Cr 12TCr 72TCr 28TCr 2,96500Cr 28TCr 27TCr 10,90000Cr | 7.85TCr 6.81TCr 6.41TCr 5.83TCr 11TCr 6,79900Cr 12TCr 76TCr 29TCr 3,11500Cr 29TCr 29TCr 11,44900Cr |
Net income | 617.7Cr 535.79Cr 504.7Cr 458.57Cr 848.38Cr 53TCr 955.89Cr 5.98TCr 2.29TCr 25TCr 2.32TCr 2.27TCr 90TCr | 648.13Cr 562.19Cr 529.56Cr 481.17Cr 890.18Cr 56TCr 1TCr 6.27TCr 2.4TCr 26TCr 2.43TCr 2.38TCr 95TCr |
Net Debt | 4.46TCr 3.87TCr 3.65TCr 3.31TCr 6.13TCr 3,86500Cr 6.91TCr 43TCr 17TCr 1,77100Cr 17TCr 16TCr 6,51000Cr | 4.54TCr 3.94TCr 3.71TCr 3.37TCr 6.24TCr 3,93600Cr 7.03TCr 44TCr 17TCr 1,80300Cr 17TCr 17TCr 6,62900Cr |
More financial data
* Estimated data
Employees
2,71,000
Calendar
Date | Price | Change | Volume |
---|---|---|---|
20/25/20 | 377.50 $ | +0.17% | 42,38,388 |
18/25/18 | 376.86 $ | +1.18% | 13,74,261 |
17/25/17 | 372.45 $ | +1.05% | 13,34,129 |
16/25/16 | 368.59 $ | -0.70% | 21,40,046 |
Delayed Quote Nyse, June 21, 2025 at 01:30 am IST
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
377.50USD
Average target price
386.48USD
Spread / Average Target
+2.38%